Report Detail
Global PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2025
- RnM2848987 |
- 31 January, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
The global PTCA Coronary Drug Eluting Balloons market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the PTCA Coronary Drug Eluting Balloons market based on company, product type, end user and key regions.
This report studies the global market size of PTCA Coronary Drug Eluting Balloons in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of PTCA Coronary Drug Eluting Balloons in these regions.
This research report categorizes the global PTCA Coronary Drug Eluting Balloons market by top players/brands, region, type and end user. This report also studies the global PTCA Coronary Drug Eluting Balloons market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
B.Braun
Spectranetics
Concept Medical
Eurocor
Lifetech
Maxcor
Micell
Qualimed
Acrostak
Market size by Product
DEB Balloon
Standard Balloon
Market size by End User
Small Vessel Disease
Bifurcation Lesions
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global PTCA Coronary Drug Eluting Balloons market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of PTCA Coronary Drug Eluting Balloons market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global PTCA Coronary Drug Eluting Balloons companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of PTCA Coronary Drug Eluting Balloons submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of PTCA Coronary Drug Eluting Balloons are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of PTCA Coronary Drug Eluting Balloons market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 PTCA Coronary Drug Eluting Balloons Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Product
- 1.4.2 DEB Balloon
- 1.4.3 Standard Balloon
- 1.5 Market by End User
- 1.5.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by End User
- 1.5.2 Small Vessel Disease
- 1.5.3 Bifurcation Lesions
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global PTCA Coronary Drug Eluting Balloons Market Size
- 2.1.1 Global PTCA Coronary Drug Eluting Balloons Revenue 2014-2025
- 2.1.2 Global PTCA Coronary Drug Eluting Balloons Sales 2014-2025
- 2.2 PTCA Coronary Drug Eluting Balloons Growth Rate by Regions
- 2.2.1 Global PTCA Coronary Drug Eluting Balloons Sales by Regions
- 2.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 PTCA Coronary Drug Eluting Balloons Sales by Manufacturers
- 3.1.1 PTCA Coronary Drug Eluting Balloons Sales by Manufacturers
- 3.1.2 PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturers
- 3.1.3 Global PTCA Coronary Drug Eluting Balloons Market Concentration Ratio (CR5 and HHI)
- 3.2 PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers
- 3.2.1 PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers (2014-2019)
- 3.2.2 PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2014-2019)
- 3.3 PTCA Coronary Drug Eluting Balloons Price by Manufacturers
- 3.4 PTCA Coronary Drug Eluting Balloons Manufacturing Base Distribution, Product Types
- 3.4.1 PTCA Coronary Drug Eluting Balloons Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers PTCA Coronary Drug Eluting Balloons Product Type
- 3.4.3 Date of International Manufacturers Enter into PTCA Coronary Drug Eluting Balloons Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global PTCA Coronary Drug Eluting Balloons Sales by Product
- 4.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Product
- 4.3 PTCA Coronary Drug Eluting Balloons Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global PTCA Coronary Drug Eluting Balloons Breakdown Data by End User
6 North America
- 6.1 North America PTCA Coronary Drug Eluting Balloons by Countries
- 6.1.1 North America PTCA Coronary Drug Eluting Balloons Sales by Countries
- 6.1.2 North America PTCA Coronary Drug Eluting Balloons Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America PTCA Coronary Drug Eluting Balloons by Product
- 6.3 North America PTCA Coronary Drug Eluting Balloons by End User
7 Europe
- 7.1 Europe PTCA Coronary Drug Eluting Balloons by Countries
- 7.1.1 Europe PTCA Coronary Drug Eluting Balloons Sales by Countries
- 7.1.2 Europe PTCA Coronary Drug Eluting Balloons Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe PTCA Coronary Drug Eluting Balloons by Product
- 7.3 Europe PTCA Coronary Drug Eluting Balloons by End User
8 Asia Pacific
- 8.1 Asia Pacific PTCA Coronary Drug Eluting Balloons by Countries
- 8.1.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Countries
- 8.1.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific PTCA Coronary Drug Eluting Balloons by Product
- 8.3 Asia Pacific PTCA Coronary Drug Eluting Balloons by End User
9 Central & South America
- 9.1 Central & South America PTCA Coronary Drug Eluting Balloons by Countries
- 9.1.1 Central & South America PTCA Coronary Drug Eluting Balloons Sales by Countries
- 9.1.2 Central & South America PTCA Coronary Drug Eluting Balloons Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America PTCA Coronary Drug Eluting Balloons by Product
- 9.3 Central & South America PTCA Coronary Drug Eluting Balloons by End User
10 Middle East and Africa
- 10.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons by Countries
- 10.1.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Countries
- 10.1.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons by Product
- 10.3 Middle East and Africa PTCA Coronary Drug Eluting Balloons by End User
11 Company Profiles
- 11.1 B.Braun
- 11.1.1 B.Braun Company Details
- 11.1.2 Company Business Overview
- 11.1.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 B.Braun PTCA Coronary Drug Eluting Balloons Products Offered
- 11.1.5 B.Braun Recent Development
- 11.2 Spectranetics
- 11.2.1 Spectranetics Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Spectranetics PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Spectranetics PTCA Coronary Drug Eluting Balloons Products Offered
- 11.2.5 Spectranetics Recent Development
- 11.3 Concept Medical
- 11.3.1 Concept Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Concept Medical PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Concept Medical PTCA Coronary Drug Eluting Balloons Products Offered
- 11.3.5 Concept Medical Recent Development
- 11.4 Eurocor
- 11.4.1 Eurocor Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Eurocor PTCA Coronary Drug Eluting Balloons Products Offered
- 11.4.5 Eurocor Recent Development
- 11.5 Lifetech
- 11.5.1 Lifetech Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Lifetech PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Lifetech PTCA Coronary Drug Eluting Balloons Products Offered
- 11.5.5 Lifetech Recent Development
- 11.6 Maxcor
- 11.6.1 Maxcor Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Maxcor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Maxcor PTCA Coronary Drug Eluting Balloons Products Offered
- 11.6.5 Maxcor Recent Development
- 11.7 Micell
- 11.7.1 Micell Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Micell PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Micell PTCA Coronary Drug Eluting Balloons Products Offered
- 11.7.5 Micell Recent Development
- 11.8 Qualimed
- 11.8.1 Qualimed Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Qualimed PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Qualimed PTCA Coronary Drug Eluting Balloons Products Offered
- 11.8.5 Qualimed Recent Development
- 11.9 Acrostak
- 11.9.1 Acrostak Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Acrostak PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Acrostak PTCA Coronary Drug Eluting Balloons Products Offered
- 11.9.5 Acrostak Recent Development
12 Future Forecast
- 12.1 PTCA Coronary Drug Eluting Balloons Market Forecast by Regions
- 12.1.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Regions 2019-2025
- 12.1.2 Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Regions 2019-2025
- 12.2 PTCA Coronary Drug Eluting Balloons Market Forecast by Product
- 12.2.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Product 2019-2025
- 12.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Product 2019-2025
- 12.3 PTCA Coronary Drug Eluting Balloons Market Forecast by End User
- 12.4 North America PTCA Coronary Drug Eluting Balloons Forecast
- 12.5 Europe PTCA Coronary Drug Eluting Balloons Forecast
- 12.6 Asia Pacific PTCA Coronary Drug Eluting Balloons Forecast
- 12.7 Central & South America PTCA Coronary Drug Eluting Balloons Forecast
- 12.8 Middle East and Africa PTCA Coronary Drug Eluting Balloons Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 PTCA Coronary Drug Eluting Balloons Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on PTCA Coronary Drug Eluting Balloons . Industry analysis & Market Report on PTCA Coronary Drug Eluting Balloons is a syndicated market report, published as Global PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of PTCA Coronary Drug Eluting Balloons market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
